CDK5RAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.235600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.939800E-01
Normal-vs-Stage2
2.145600E-01
Normal-vs-Stage3
1.477780E-01
Normal-vs-Stage4
5.639400E-01
Stage1-vs-Stage2
7.471600E-01
Stage1-vs-Stage3
1.396750E-01
Stage1-vs-Stage4
4.838400E-01
Stage2-vs-Stage3
6.406200E-02
Stage2-vs-Stage4
7.247600E-01
Stage3-vs-Stage4
8.241800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.459200E-01
Normal-vs-AfricanAmerican
3.184800E-01
Normal-vs-Asian
3.261200E-01
Caucasian-vs-AfricanAmerican
1.261840E-01
Caucasian-vs-Asian
9.499600E-01
AfricanAmerican-vs-Asian
1.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.160400E-01
Normal-vs-Female
2.553000E-01
Male-vs-Female
9.420200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.950800E-01
Normal-vs-Age(41-60Yrs)
3.849600E-01
Normal-vs-Age(61-80Yrs)
2.015600E-01
Normal-vs-Age(81-100Yrs)
4.787400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.182800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.702600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.082800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.650200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.384400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.303000E-01
Normal-vs-Daily Drinker
5.598800E-01
Normal-vs-Weekly Drinker
3.685200E-01
Normal-vs-Occasional Drinker
2.335600E-01
Normal-vs-Social Drinker
7.345400E-01
Non Drinker-vs-Daily Drinker
1.623800E-01
Non Drinker-vs-Weekly Drinker
3.304800E-01
Non Drinker-vs-Occasional Drinker
5.898200E-01
Non Drinker-vs-Social Drinker
9.825700E-02
Daily Drinker-vs-Weekly Drinker
7.256000E-01
Daily Drinker-vs-Occasional Drinker
3.686400E-01
Daily Drinker-vs-Social Drinker
6.715600E-01
Weekly Drinker-vs-Occasional Drinker
5.615400E-01
Weekly Drinker-vs-Social Drinker
4.452200E-01
Occasional Drinker-vs-Social Drinker
1.979360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.933000E-01
Normal-vs-Grade 2
5.955200E-01
Normal-vs-Grade 3
6.196200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.163400E-01
Grade 1-vs-Grade 3
5.136600E-01
Grade 1-vs-Grade 4
2.933000E-01
Grade 2-vs-Grade 3
5.603400E-01
Grade 2-vs-Grade 4
5.955200E-01
Grade 3-vs-Grade 4
6.196200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.633800E-01
Normal-vs-NonDiabetic
2.777600E-01
Diabetic-vs-NonDiabetic
5.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.758200E-01
Normal-vs-NoPancreatitis
2.155800E-01
Pancreatitis-vs-NoPancreatitis
2.185200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.697400E-01
Normal-vs-N1
1.929030E-01
N0-vs-N1
2.583400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.138400E-01
Normal-vs-TP53-NonMutant
3.973600E-01
TP53-Mutant-vs-TP53-NonMutant
6.690000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
